Divine Aleru

Divine Aleru, Microbiome Signatures Research Coordinator

About

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

Recent Posts

2025-09-12

Assessing Acute and Chronic Risks of Human Exposure to Arsenic

This study assessed acute and chronic arsenic exposure in an Ethiopian population, finding significant health risks associated with contaminated groundwater and cigarette smoking. Biomarkers like urine and nail arsenic levels were key in understanding exposure.

2025-09-12

Role of Probiotics in the Management of Helicobacter pylori

This review examines the use of probiotics in managing H. pylori infection, emphasizing their role in enhancing eradication rates, reducing side effects, and restoring gastric microbiota balance. The findings highlight the potential of probiotics as adjuncts to conventional antibiotic therapy.

2025-09-11

Arsenic toxicity: Sources, pathophysiology and mechanism

This review examines arsenic toxicity, its pathways of exposure, and its harmful effects on human health, focusing on oxidative stress, genotoxicity, and epigenetic changes. It highlights the link between arsenic exposure and diseases like cancer, cardiovascular disorders, and neurotoxicity.

2025-09-11

Arsenic binding to human metallothionein-3

This study investigates how arsenic(III) binds to human metallothionein-3, revealing detailed binding kinetics and the role of MT3 in arsenic detoxification. These findings have implications for understanding arsenic poisoning and potential therapeutic strategies.

2025-09-11

Arsenic Binding to Proteins

This review examines how arsenic binds to proteins, disrupting their function and contributing to toxicity and resistance mechanisms. It highlights key proteins like thioredoxin and pyruvate dehydrogenase and discusses implications for arsenic-related diseases and bioremediation strategies.

2025-09-10

An arsenic metallochaperone for an arsenic detoxification pump

The study explores how ArsD, a metallochaperone, enhances ArsA’s ability to expel arsenic from cells, improving arsenic detoxification. This interaction increases arsenic resistance in E. coli, with potential applications in bioremediation and combating arsenic poisoning.

2025-09-10

The ArsD As(III) metallochaperone

This study investigates the structural and biochemical role of ArsD, a metallochaperone in E. coli, in enhancing arsenic detoxification by transferring As(III) to the ArsA ATPase, providing new insights into arsenic resistance mechanisms in bacteria.

2025-09-10

Introducing the ArsR-Regulated Arsenic Stimulon

This study explored the complex regulatory roles of ArsR proteins in Agrobacterium tumefaciens 5A, showing they influence a broad range of cellular functions, including arsenic resistance, metabolism, and iron homeostasis.

2025-09-10

Distribution of Arsenic Resistance Genes in Prokaryotes

This review outlines the diversity, evolution, and distribution of arsenic resistance genes in prokaryotes, emphasizing their central role in the environmental microbiome, biogeochemical cycling, and potential clinical implications through gene transfer and resistance in pathogens.

2025-09-10

The Human Gut Microbiome’s Influence on Arsenic Toxicity

The human gut microbiome and arsenic toxicity are tightly linked: microbes change arsenic speciation and dose, while arsenic reshapes gut ecology, altering risk. Clinicians should integrate microbiome status, nutrition, antibiotics history, and speciation into assessment and management.